2025-05-24 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc. (TDOC) based on the provided data. The report is structured to provide a quick overview with key numbers, followed by more detailed analysis.

## Teladoc Health Inc. (TDOC) Analysis

**Company Overview:** Teladoc Health Inc. is a telehealth company that provides virtual healthcare services.

### 1. Performance vs. S&P 500 (VOO)

*   **TDOC Cumulative Return:** -70.63%
*   **VOO Cumulative Return:** 80.60%
*   **Absolute Divergence (Current):** -151.2
*   **Relative Divergence:** 2.1

**Analysis:** TDOC has significantly underperformed the S&P 500 (VOO) over the period reflected in the cumulative return data. The relative divergence of 2.1 indicates that its underperformance is near the lower end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha   | Beta   | Cap(B) |
|------------|---------|--------|---------|--------|--------|
| 2015-2017  | 76.0%   | 60.6%  | 49.0%   | -0.0   | 6.1    |
| 2016-2018  | 128.0%  | 59.3%  | 110.0%  | 0.0    | 8.7    |
| 2017-2019  | 176.0%  | 59.3%  | 147.0%  | 0.4    | 14.7   |
| 2018-2020  | 237.0%  | 64.0%  | 211.0%  | 0.2    | 35.1   |
| 2019-2021  | -83.0%  | 64.0%  | -138.0% | 0.2    | 16.1   |
| 2020-2022  | -295.0% | 81.3%  | -301.0% | 0.0    | 4.2    |
| 2021-2023  | -488.0% | 81.3%  | -505.0% | -0.6   | 3.8    |
| 2022-2024  | -111.0% | 81.3%  | -128.0% | -0.9   | 1.6    |
| 2023-2025  | -41.0%  | 72.9%  | -68.0%  | -0.8   | 1.2    |

**Analysis:**

*   **CAGR:** Initially showed strong growth (2015-2020), but significantly declined in later periods.
*   **MDD:** High Maximum Drawdown indicates significant volatility and potential risk.
*   **Alpha:** Consistently positive in early years, indicating outperformance against the benchmark, but turned sharply negative, suggesting underperformance.
*   **Beta:** Relatively low and close to zero, suggesting low correlation with the market; however, it has become negative in recent years, implying that the stock moves inversely to the market.
*   **Cap(B):** Market capitalization has decreased significantly over the years, reflecting the stock's decline.

### 2. Recent Price Action

*   **Last Price:** 6.81
*   **Previous Close:** 6.90
*   **Change:** -1.3%
*   **5-day Moving Average:** 7.066
*   **20-day Moving Average:** 7.156
*   **60-day Moving Average:** 7.767

**Analysis:**  The stock price is currently below all three moving averages, suggesting a downtrend.  The negative change from the previous close indicates continued downward pressure.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3656 (Low Risk)
*   **RSI:** 43.51 (Neutral)
*   **PPO:** 0.0298
*   **20-day Relative Divergence Change:** 0.2 (Positive - Short-term Increase)
*   **Expected Return (%):** -4325.4%

**Analysis:**

*   The MRI indicates a low-risk environment.
*   RSI is neutral, not indicating overbought or oversold conditions.
*   The positive change in relative divergence suggests a potential short-term upward movement.
*   The extremely negative expected return suggests significant long-term underperformance compared to the S&P 500, calling into question its viability as a long-term investment.

### 4. Recent News & Significant Events

*   **May 21, 2025:** Major business developments, regulatory changes, or market events.
*   **May 20, 2025:** Analysts discussing performance and outlook.
*   **May 23, 2025:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **May 22, 2025:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news suggests volatility and ongoing discussions about the company's performance and outlook.  Investors should monitor news and company announcements closely.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-05-01 | -0.53 | 0.63 B$   |
| 2024-10-31 | -0.19 | 0.64 B$   |
| 2024-08-01 | -4.92 | 0.64 B$   |
| 2024-04-26 | -0.49 | 0.65 B$   |
| 2025-05-01 | -0.49 | 0.65 B$   |

**Analysis:**  The company consistently reports negative EPS. Revenue has been relatively stable. The large negative EPS in August 2024 is concerning and may be due to a one-time write-down or other significant event.

### 6. Financial Information:

Revenue and Profitability:

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.63B  | 68.73%        |
| 2024-12-31 | $0.64B  | 70.50%        |
| 2024-09-30 | $0.64B  | 71.94%        |
| 2024-06-30 | $0.64B  | 70.73%        |
| 2024-03-31 | $0.65B  | 69.89%        |

Capital and Profitability:

| Quarter    | Equity  | ROE       |
|------------|---------|-----------|
| 2025-03-31 | $1.43B  | -6.52%    |
| 2024-12-31 | $1.49B  | -3.25%    |
| 2024-09-30 | $1.51B  | -2.21%    |
| 2024-06-30 | $1.50B  | -55.77%   |
| 2024-03-31 | $2.29B  | -3.58%    |

**Analysis:**

*   Revenue is stable. Profit margins are relatively high.
*   Equity has been decreasing, and ROE is consistently negative, indicating poor profitability and inefficient use of equity. The significant ROE drop in June 2024 mirrors the EPS decline seen earlier.

### 7. Overall Analysis

Teladoc Health Inc. (TDOC) is currently facing significant challenges. The company has underperformed the S&P 500 substantially, with negative expected returns suggesting continued struggles. While revenue has been stable and profit margins are high, negative EPS and ROE indicate underlying profitability issues. Decreasing equity and significant ROE drops further highlight the company's financial difficulties.

Recent news suggests volatility and ongoing analyst scrutiny. Technically, the stock is in a downtrend, although short-term indicators show a potential for a slight rebound.

**Overall Recommendation:** Based on the provided data, a cautious approach is warranted. Further investigation into the reasons for the negative earnings and declining equity is necessary before considering any investment.
